期刊文献+
共找到49篇文章
< 1 2 3 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
7
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
8
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
9
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
10
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
11
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
异烟肼对小鼠非特异性免疫功能的影响 被引量:5
12
作者 毛泽善 范雪辉 +2 位作者 马全祥 宋向凤 杨廷桐 《陕西医学杂志》 CAS 北大核心 2004年第4期306-307,F003,共3页
目的 :探讨异烟肼对小鼠免疫功能的影响。方法 :将 2 0只小鼠随机等分为对照组和实验组 ,对照组用清水喂食 ,实验组用 0 .5 mg/ml的异烟肼喂食 ,1 0 d后检测小鼠腹腔巨噬细胞内酸性磷酸酶活性的变化以及巨噬细胞吞噬功能的变化。结果 :... 目的 :探讨异烟肼对小鼠免疫功能的影响。方法 :将 2 0只小鼠随机等分为对照组和实验组 ,对照组用清水喂食 ,实验组用 0 .5 mg/ml的异烟肼喂食 ,1 0 d后检测小鼠腹腔巨噬细胞内酸性磷酸酶活性的变化以及巨噬细胞吞噬功能的变化。结果 :与对照组相比 ,实验组小鼠腹腔巨噬细胞酸性磷酸酶活性增加 ,巨噬细胞的吞噬功能也有所增强。结论 展开更多
关键词 异烟肼 小鼠 非特异性免疫功能 药物作用 酸性磷酸酶类
下载PDF
异烟肼血药浓度的影响因素分析 被引量:7
13
作者 张亮 冯枭 +3 位作者 林霏申 周秋云 丁红梓 王洁 《药学与临床研究》 2018年第6期413-416,共4页
目的:分析影响异烟肼血药浓度的因素。方法:对2013年9月~2017年12月的97例异烟肼血药浓度监测患者作回顾性分析,探讨影响异烟肼血药浓度的主要因素。结果:该药血药浓度与体表面积和白蛋白水平存在显著相关性。结论:密切关注具有危险因... 目的:分析影响异烟肼血药浓度的因素。方法:对2013年9月~2017年12月的97例异烟肼血药浓度监测患者作回顾性分析,探讨影响异烟肼血药浓度的主要因素。结果:该药血药浓度与体表面积和白蛋白水平存在显著相关性。结论:密切关注具有危险因素患者的血药浓度。 展开更多
关键词 异烟肼 血药浓度监测 影响因素
下载PDF
结核多表位DNA疫苗免疫效果及其对小鼠耐药结核病的疗效观察 被引量:2
14
作者 刘敏 孙钢 刘如意 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2014年第3期311-314,共4页
目的研究比较结核分枝杆菌Hsp70、Ag85A、ESAT-6多表位DNA疫苗和卡介苗(BCG)的免疫效果,观察该疫苗联合抗结核药物治疗耐药结核病小鼠的疗效。方法随机将BALB/c小鼠分成A、B、C组,分别用PBS、BCG和多表位DNA疫苗经皮下免疫,1、3、5周各... 目的研究比较结核分枝杆菌Hsp70、Ag85A、ESAT-6多表位DNA疫苗和卡介苗(BCG)的免疫效果,观察该疫苗联合抗结核药物治疗耐药结核病小鼠的疗效。方法随机将BALB/c小鼠分成A、B、C组,分别用PBS、BCG和多表位DNA疫苗经皮下免疫,1、3、5周各免疫1次。免疫后眼球采血,分离血清,用酶联免疫吸附试验(ELISA)间接法测定特异性IgG抗体,用ELISA双抗体夹心法测定IL2和IFN-γ;同时分离小鼠脾细胞,用MTT法测定淋巴细胞增殖指数。为观察多表位疫苗的疗效,小鼠尾静脉注射结核分枝杆菌双耐菌株(耐利福平和耐异烟肼),4周后将感染模型小鼠随机分成D、E、F 3组,其中D组为阴性对照,注射生理盐水;E组用利福平、异烟肼治疗;F组为联合用药组,用结核分枝杆菌Hsp70、Ag85A、ESAT-6多表位DNA疫苗和利福平、异烟肼联合治疗,疗程均为10周。治疗结束后称取小鼠体重,取其肺、肝、脾,称取质量,并作肺和脾脏菌落计数。结果多表位DNA疫苗组小鼠血清特异性IgG抗体、IL2、IFN-γ和淋巴细胞增殖指数均明显高于PBS组和BCG组(P<0.05);多表位DNA疫苗联合抗结核化疗药能明显降低耐药结核病小鼠肺、脾菌落计数和肺、肝和脾脏指数(P<0.05)。结论结核分枝杆菌Hsp70、Ag85A、ESAT-6多表位DNA疫苗能在小鼠体内诱导较强的特异性免疫反应,产生高水平的特异性IgG抗体、诱导IL2和IFN-γ分泌和特异性淋巴细胞增殖,并能显著提高抗结核药物对耐药结核病小鼠的疗效。 展开更多
关键词 结核分枝杆菌 表位 DNA疫苗 免疫 疗效 HSP70 异烟肼 利福平
下载PDF
常规抗结核治疗联合异烟肼鞘内注射治疗结核性脑膜炎合并结核瘤的疗效观察(附3例报告) 被引量:16
15
作者 嵇虎 笪正 +1 位作者 陈道文 陈洁 《临床神经病学杂志》 CAS 北大核心 2014年第5期378-380,共3页
目的观察常规抗结核治疗联合异烟肼鞘内注射治疗结核性脑膜炎合并结核瘤的疗效。方法回顾性分析3例结核性脑膜炎合并结核瘤患者经常规抗结核治疗联合异烟肼鞘内注射治疗后的临床表现、CSF及影像学改变。结果本组3例患者均亚急性起病,病... 目的观察常规抗结核治疗联合异烟肼鞘内注射治疗结核性脑膜炎合并结核瘤的疗效。方法回顾性分析3例结核性脑膜炎合并结核瘤患者经常规抗结核治疗联合异烟肼鞘内注射治疗后的临床表现、CSF及影像学改变。结果本组3例患者均亚急性起病,病程中或治疗过程中合并出现结核瘤,经常规抗结核治疗联合鞘内注射治疗(异烟肼0.1 g+地塞米松5 mg),临床症状缓解,CSF恢复正常,影像学示脑部病灶消失。结论对于结核性脑膜炎合并结核瘤来说,常规抗结核治疗联合异烟肼鞘内注射治疗也许是一个有效的治疗方案。 展开更多
关键词 结核性脑膜炎 结核瘤 鞘内注射 异烟肼 疗效
下载PDF
新型在线柱萃取高效液相色谱法测定异烟肼的血药浓度 被引量:2
16
作者 谢烨 李威 +2 位作者 周争朝 李焕德 王峰 《中南药学》 CAS 2013年第8期568-571,共4页
目的建立新型在线柱萃取HPLC法测定人血浆中异烟肼血药浓度,用于异烟肼的日常治疗药物监测。方法新型在线柱萃取HPLC由萃取系统和分析系统两部分构成。萃取柱为Aston RG SCX(20 mm×4.6 mm,5μm,ANAX),分析柱为Aston RG C18(250 mm&... 目的建立新型在线柱萃取HPLC法测定人血浆中异烟肼血药浓度,用于异烟肼的日常治疗药物监测。方法新型在线柱萃取HPLC由萃取系统和分析系统两部分构成。萃取柱为Aston RG SCX(20 mm×4.6 mm,5μm,ANAX),分析柱为Aston RG C18(250 mm×4.6 mm,5μm);两系统通过六通阀连接,采用"中心切割"模式及陷阱柱转移目标物;检测波长为340 nm,样品经蛋白沉淀、衍生,进样量为50μL,采用外标法计算结果。结果异烟肼在0.18~35.84μg.mL-1与峰面积呈良好线性关系,相关系数为0.999 8,最低检测限为0.02μg.mL-1,低(0.18μg.mL-1)、中(2.24μg.mL-1)、高(35.84μg.mL-1)浓度的绝对回收率为91.6%~95.9%,日内和日间RSD均<5.0%,准确度为98.7%~101.5%。结论本方法具有抗干扰能力强、自动化程度高、准确度和精密度好等优点,完全适合异烟肼的日常治疗药物监测。 展开更多
关键词 新型在线柱萃取 高效液相色谱法 异烟肼 治疗药物监测
下载PDF
异烟肼唾液浓度与血药浓度及其相关性研究 被引量:1
17
作者 李青 龙明立 +1 位作者 曾建国 欧艳 《解放军药学学报》 CAS 2010年第4期324-327,共4页
目的探讨结核患者异烟肼唾液浓度与血药浓度的相关性。方法选择长沙市中心医院2007年9月至2009年3月住院患者202例,服药达稳态血药浓度后,采集肘静脉血2ml,并同时收集自然状态下分泌的唾液1ml,用反相高效液相色谱法同时测定唾液浓度与... 目的探讨结核患者异烟肼唾液浓度与血药浓度的相关性。方法选择长沙市中心医院2007年9月至2009年3月住院患者202例,服药达稳态血药浓度后,采集肘静脉血2ml,并同时收集自然状态下分泌的唾液1ml,用反相高效液相色谱法同时测定唾液浓度与血药浓度。结果异烟肼血清浓度与唾液浓度的回归方程分别为C=1.34×10-5A-0.25(r=0.9958)和C=4.07×10-6A-0.30(r=0.9921)。异烟肼唾液浓度与血药浓度回归方程为Y=2.54×10-1X-1.09×10-2(n=202,r=0.8985,P<0.01),其比值为(24.89±3.90)%。结论异烟肼唾液浓度与血药浓度具有显著的相关性,可以用唾液代替血清对异烟肼作治疗药物监测;异烟肼唾液/血清药物浓度比不受性别、年龄影响,其间无相关性。 展开更多
关键词 异烟肼 血药监测 唾液浓度 血药浓度 相关性
下载PDF
护肝益肺颗粒抗异烟肼肝损害的实验研究 被引量:8
18
作者 武谦虎 樊一桥 +2 位作者 王雪梅 龚玉华 盛健惠 《中西医结合肝病杂志》 CAS 2004年第3期149-151,共3页
目的 :观察护肝益肺颗粒对异烟肼致肝损害小鼠的防护作用。方法 :分别测定肝损害组和护肝益肺颗粒组小鼠的血清ALT、AST、ALP、肝指数 ,观察肝细胞的镜下改变 ,并与正常对照组及阳性对照组比较。结果 :护肝益肺颗粒能对抗异烟肼引起的血... 目的 :观察护肝益肺颗粒对异烟肼致肝损害小鼠的防护作用。方法 :分别测定肝损害组和护肝益肺颗粒组小鼠的血清ALT、AST、ALP、肝指数 ,观察肝细胞的镜下改变 ,并与正常对照组及阳性对照组比较。结果 :护肝益肺颗粒能对抗异烟肼引起的血清ALT、AST、ALP增高 ,减轻异烟肼对肝细胞的损害。肝损害组与正常对照组和护肝益肺颗粒组比较 ,差异均有显著性意义 (P <0 0 1) ,且护肝益肺颗粒组优于阳性对照组 (P <0 0 5 )。结论 :护肝益肺颗粒对异烟肼所致肝损害具有防护作用。 展开更多
关键词 护肝益肺颗粒 异烟肼 肝损害 副作用 肝保护 给药方法
下载PDF
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy 被引量:19
19
作者 Perdita Wietzke-Braun Volker Meier +1 位作者 Felix Braun Giuliano Ramadori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期222-227,共6页
AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chron... AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chronic hepatitis C virus-infected non-responders to interferon alfa2a monotherapy (a course of at least 3 months treatment) and 13 relapsers to interferon alfa 2a monotherapy (a dose of 3 to 6 million units three times per week for at least 20 weeks but not more than 18 months) were treated with the same dose of interferon alfa-2a used before (3 to 6 million units three times per week) and ribavirin (10 mg/ kg daily) for 6 months. In complete responders, interferon alfa-2a was administered for further 6 months at the same dose used before as monotherapy.RESULTS Seven (20.6%) of 34 non-responders stopped the combined therapy due to adverse events, including two patients with histological and clinical Child A cirrhosis. In 17/27 (63%)non-responders, the combined therapy was stopped after three months because of non-response. Ten of the 27 non-responders completed the 1;2-month treatment course. At a mean follow up of 28 months (16- 37 months)after the treatment, 4/10 (15%) previous non-responders still remained complete responders,All 13 previous relapsers completed the 12-month treatment course. At a mean follow up of 22months (9 - 36 months) after treatment, 6/13(46%) the previous relapsers were stillsustained complete responders.CONCLUSION Our treatment schedule of the combined therapy for 6 months of interferon alfa2a with a low dose of ribavirin (10 mg/kg/day)followed by 6 months of interferon alfa-2amonotherapy is able to induce a sustainedcomplete response rate in 15% of non-responders and 46% of relapsers with chronic hepatitis C virus-related liver diseases comparable to those obtained with the standarddoses of ribavirin 1000 - 1200 mg/day.Randomized prospective controlled trials using lower total amounts of ribavirin in combination with interferon should be performed. 展开更多
关键词 hepatitis C chronic/drug therapy INTERFERON alpha-2a/therapeutic use INTERFERON alpha-2a/administration & DOSAGE ribavirin/administration & DOSAGE ribavirin/therapeutic use
下载PDF
Probiotic mixture VSL#3:An overview of basic and clinical studies in chronic diseases 被引量:11
20
作者 Fang-Shu Cheng Dan Pan +2 位作者 Bing Chang Min Jiang Li-Xuan Sang 《World Journal of Clinical Cases》 SCIE 2020年第8期1361-1384,共24页
Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted co... Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted considerable attention for its combined effect.VSL#3 is the only probiotic considered as a kind of medical food;it mainly participates in the regulation of the intestinal barrier function,including improving tight junction protein function,balancing intestinal microbial composition,regulating immune-related cytokine expression and so on.The objective of this review is to discuss the treatment action and mechanism for the administration of VSL#3 in chronic diseases of animals and humans(including children).We found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies,including digestive systemic diseases(gastrointestinal diseases and hepatic diseases),obesity and diabetes,allergic diseases,nervous systemic diseases,atherosclerosis,bone diseases,and female reproductive systemic diseases. 展开更多
关键词 VSL#3 INTESTINAL barrier function CHRONIC DISEASES INTESTINAL MICROBIAL balance CYTOKINES therapeutic use
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部